<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02615665</url>
  </required_header>
  <id_info>
    <org_study_id>NKTCellsInCLM</org_study_id>
    <nct_id>NCT02615665</nct_id>
  </id_info>
  <brief_title>Intratumoral CD3+ and NKp46+ Cells in Colorectal Liver Metastases</brief_title>
  <official_title>Role of CD3+ and NKp46+ Cells in Resected Colorectal Liver Metastases.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Milan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Milan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The long-term outcome of patients resected for colorectal liver metastases (CLM) after
      neoadjuvant chemotherapy (CHT) depends by several tumoral and non-tumoral factors, such as
      the immune response to the tumor and to the CHT. The aim of this study was to investigate the
      impact of the pathological and immunological response in patients undergoing liver resection
      for CLM after CHT in regards to the long-term outcome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The immunoreactivity to CD3+ and NKp46+ cells inside the tumor, at the border between the
      tumor and the normal liver, and inside the normal liver will be tested by computer-assisted
      image analyses in patients undergoing liver resection for CLM between 2005 and 2013
      preoperatively treated with oxaliplatin or irinotecan with or without bevacizumab or
      cetuximab. The survival will be assessed in relation to several prognostic factors and to
      that immunoreactivity.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Overall survival</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <enrollment type="Actual">121</enrollment>
  <condition>Colorectal Liver Metastases</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hepatic resection</intervention_name>
    <description>Removal of a part of the liver during surgery</description>
    <other_name>Hepatectomy; liver resection; liver surgery</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      We use the surgical specimens.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with colorectal liver metastases scheduled for surgery at our Unit.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  histological proven colorectal liver metastases

          -  complete clinical, surgical, pathological and follow-up data

        Exclusion Criteria:

          -  non-radical surgery

          -  incomplete clinical, surgical, pathological and follow-up data
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guido Torzilli, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Humanitas University, Humanitas Research Hospital IRCCS</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Hepatobiliary and General Surgery, Humanitas Research Hospital, University of Milan</name>
      <address>
        <city>Rozzano</city>
        <state>Milan</state>
        <zip>20089</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <results_reference>
    <citation>Hudspeth K, Donadon M, Cimino M, Pontarini E, Tentorio P, Preti M, Hong M, Bertoletti A, Bicciato S, Invernizzi P, Lugli E, Torzilli G, Gershwin ME, Mavilio D. Human liver-resident CD56(bright)/CD16(neg) NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways. J Autoimmun. 2016 Jan;66:40-50. doi: 10.1016/j.jaut.2015.08.011. Epub 2015 Aug 30.</citation>
    <PMID>26330348</PMID>
  </results_reference>
  <results_reference>
    <citation>Hudspeth K, Pontarini E, Tentorio P, Cimino M, Donadon M, Torzilli G, Lugli E, Della Bella S, Gershwin ME, Mavilio D. The role of natural killer cells in autoimmune liver disease: a comprehensive review. J Autoimmun. 2013 Oct;46:55-65. doi: 10.1016/j.jaut.2013.07.003. Epub 2013 Jul 21. Review.</citation>
    <PMID>23880068</PMID>
  </results_reference>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 18, 2015</study_first_submitted>
  <study_first_submitted_qc>November 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 26, 2015</study_first_posted>
  <last_update_submitted>November 24, 2015</last_update_submitted>
  <last_update_submitted_qc>November 24, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 26, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Milan</investigator_affiliation>
    <investigator_full_name>Prof. Guido Torzilli</investigator_full_name>
    <investigator_title>Professor of Surgery</investigator_title>
  </responsible_party>
  <keyword>NK-cells</keyword>
  <keyword>T-cells</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Liver Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

